Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on December 12, 2005

Circulation. 2005
Published online before print December 12, 2005, doi: 10.1161/CIRCULATIONAHA.105.543124
A more recent version of this article appeared on December 20, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
112/25/3937    most recent
CIRCULATIONAHA.105.543124v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rissanen, T. T.
Right arrow Articles by Ylä-Herttuala, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rissanen, T. T.
Right arrow Articles by Ylä-Herttuala, S.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Genes and Gene Therapy
Related Collections
Right arrow Peripheral vascular disease
Right arrow Gene therapy
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Angiogenesis
Right arrow CT and MRI
Right arrow Growth factors/cytokines

Submitted on February 15, 2005
Revised on October 4, 2005
Accepted on October 11, 2005

Blood Flow Remodels Growing Vasculature During Vascular Endothelial Growth Factor Gene Therapy and Determines Between Capillary Arterialization and Sprouting Angiogenesis

Tuomas T. Rissanen MD, PhD, Petra Korpisalo MD, Johanna E. Markkanen MD, Timo Liimatainen MSc, Maija-Riitta Ordén MD, PhD, Ivana Kholová MD, PhD, Anna de Goede MSc, Tommi Heikura MSc, Olli H. Gröhn PhD, and Seppo Ylä-Herttuala MD, PhD, FESC*

From the Departments of Biotechnology and Molecular Medicine (T.T.R., P.K., J.E.M., I.K., A.d.G., T.H., S.Y.-H.) and Biomedical NMR and National Bio NMR Facility (T.L., O.H.G.), A.I. Virtanen Institute, Kuopio University; Department of Gynecology and Obstetrics, Kuopio University Hospital (M.O.); Department of Medicine, Kuopio University (S.Y.-H.); and Gene Therapy Unit, Kuopio University Hospital (S.Y.-H.), Kuopio, Finland.

* To whom correspondence should be addressed. E-mail: Seppo.Ylaherttuala{at}uku.fi.

Background--For clinically relevant proangiogenic therapy, it would be essential that the growth of the whole vascular tree is promoted. Vascular endothelial growth factor (VEGF) is well known to induce angiogenesis, but its capability to promote growth of larger vessels is controversial. We hypothesized that blood flow remodels vascular growth during VEGF gene therapy and may contribute to the growth of large vessels.

Methods and Results--Adenoviral (Ad) VEGF or LacZ control gene transfer was performed in rabbit hindlimb semimembranous muscles with or without ligation of the profound femoral artery (PFA). Contrast-enhanced ultrasound and dynamic susceptibility contrast MRI demonstrated dramatic 23- to 27-fold increases in perfusion index and a strong decrease in peripheral resistance 6 days after AdVEGF gene transfer in normal muscles. Enlargement by 20-fold, increased pericyte coverage, and decreased alkaline phosphatase and dipeptidyl peptidase IV activities suggested the transformation of capillaries toward an arterial phenotype. Increase in muscle perfusion was attenuated, and blood vessel growth was more variable, showing more sprouting angiogenesis and formation of blood lacunae after AdVEGF gene transfer in muscles with ligated PFA than in normal muscles. Three-dimensional ultrasound reconstructions and histology showed that the whole vascular tree, including large arteries and veins, was enlarged manifold by AdVEGF. Blood flow was normalized and enlarged collaterals persisted in operated limbs 14 days after AdVEGF treatment.

Conclusions--This study shows that (1) blood flow modulates vessel growth during VEGF gene therapy and (2) VEGF overexpression promotes growth of arteries and veins and induces capillary arterialization leading to supraphysiological blood flow in target muscles.


Key words: angiogenesis • gene therapy • ischemia • perfusion • peripheral vascular disease




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. V. Benest, O. A. Stone, W. H. Miller, C. P. Glover, J. B. Uney, A. H. Baker, S. J. Harper, and D. O. Bates
Arteriolar Genesis and Angiogenesis Induced by Endothelial Nitric Oxide Synthase Overexpression Results in a Mature Vasculature
Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1462 - 1468.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. E. Hartnett, D. Martiniuk, G. Byfield, P. Geisen, G. Zeng, and V. L. Bautch
Neutralizing VEGF Decreases Tortuosity and Alters Endothelial Cell Division Orientation in Arterioles and Veins in a Rat Model of ROP: Relevance to Plus Disease
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3107 - 3114.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
C Kalka and I. Baumgartner
Gene and stem cell therapy in peripheral arterial occlusive disease
Vascular Medicine, May 1, 2008; 13(2): 157 - 172.
[Abstract] [PDF]


Home page
Circ. Res.Home page
H. Viita, J. Markkanen, E. Eriksson, M. Nurminen, K. Kinnunen, M. Babu, T. Heikura, S. Turpeinen, S. Laidinen, T. Takalo, et al.
15-Lipoxygenase-1 Prevents Vascular Endothelial Growth Factor A- and Placental Growth Factor-Induced Angiogenic Effects in Rabbit Skeletal Muscles via Reduction in Growth Factor mRNA Levels, NO Bioactivity, and Downregulation of VEGF Receptor 2 Expression
Circ. Res., February 1, 2008; 102(2): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
T. T. Rissanen, P. Korpisalo, H. Karvinen, T. Liimatainen, S. Laidinen, O. H. Grohn, and S. Yla-Herttuala
High-Resolution Ultrasound Perfusion Imaging of Therapeutic Angiogenesis
J. Am. Coll. Cardiol. Img., January 1, 2008; 1(1): 83 - 91.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
X. Hao, E. A. Silva, A. Mansson-Broberg, K.-H. Grinnemo, A. J. Siddiqui, G. Dellgren, E. Wardell, L. A. Brodin, D. J. Mooney, and C. Sylven
Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction
Cardiovasc Res, July 1, 2007; 75(1): 178 - 185.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Saeed, D. Saloner, A. Martin, L. Do, O. Weber, P. C. Ursell, A. Jacquier, R. Lee, and C. B. Higgins
Adeno-associated Viral Vector-Encoding Vascular Endothelial Growth Factor Gene: Effect on Cardiovascular MR Perfusion and Infarct Resorption Measurements in Swine
Radiology, May 1, 2007; 243(2): 451 - 460.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Yla-Herttuala, T. T. Rissanen, I. Vajanto, and J. Hartikainen
Vascular Endothelial Growth Factors: Biology and Current Status of Clinical Applications in Cardiovascular Medicine
J. Am. Coll. Cardiol., March 13, 2007; 49(10): 1015 - 1026.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. von Degenfeld, A. Banfi, M. L. Springer, R. A. Wagner, J. Jacobi, C. R. Ozawa, M. J. Merchant, J. P. Cooke, and H. M. Blau
Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia
FASEB J, December 1, 2006; 20(14): 2657 - 2659.
[Abstract] [Full Text] [PDF]